These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29079715)

  • 1. Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.
    Jun M; Ohkuma T; Zoungas S; Colagiuri S; Mancia G; Marre M; Matthews D; Poulter N; Williams B; Rodgers A; Perkovic V; Chalmers J; Woodward M;
    Diabetes Care; 2018 Jan; 41(1):163-170. PubMed ID: 29079715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.
    Ohkuma T; Jun M; Chalmers J; Cooper ME; Hamet P; Harrap S; Zoungas S; Perkovic V; Woodward M;
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):862-872. PubMed ID: 31160317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
    Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis.
    Jardine M; Zhou Z; Lambers Heerspink HJ; Hockham C; Li Q; Agarwal R; Bakris GL; Cannon CP; Charytan DM; Greene T; Levin A; Li JW; Neuen BL; Neal B; Oh R; Oshima M; Pollock C; Wheeler DC; de Zeeuw D; Zhang H; Zinman B; Mahaffey KW; Perkovic V
    Clin J Am Soc Nephrol; 2021 Mar; 16(3):384-395. PubMed ID: 33619120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine Albumin/Creatinine Ratio Below 30 mg/g is a Predictor of Incident Hypertension and Cardiovascular Mortality.
    Sung KC; Ryu S; Lee JY; Lee SH; Cheong E; Hyun YY; Lee KB; Kim H; Byrne CD
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27625343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the longitudinal trajectory of urinary albumin/creatinine ratio in diabetic patients with adverse cardiac event risk: a retrospective cohort study.
    Li H; Ren Y; Duan Y; Li P; Bian Y
    Front Endocrinol (Lausanne); 2024; 15():1355149. PubMed ID: 38745945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression.
    Neuen BL; Weldegiorgis M; Herrington WG; Ohkuma T; Smith M; Woodward M
    Am J Kidney Dis; 2021 Sep; 78(3):350-360.e1. PubMed ID: 33895181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.
    Rasaratnam N; Salim A; Blackberry I; Cooper ME; Magliano DJ; van Wijngaarden P; Varadarajan S; Sacre JW; Shaw JE
    Am J Kidney Dis; 2024 Jul; 84(1):8-17.e1. PubMed ID: 38551531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary non-albumin protein-creatinine ratio is an independent predictor of mortality in patients with type 2 diabetes: a retrospective cohort study.
    Cheng YC; Lu CL; Hsu CY; Sheu ML; Lee IT
    Sci Rep; 2024 May; 14(1):10526. PubMed ID: 38719892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.
    Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M
    BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.
    Oshima M; Jun M; Ohkuma T; Toyama T; Wada T; Cooper ME; Hadjadj S; Hamet P; Harrap S; Mancia G; Marre M; Williams B; Chalmers J; Woodward M; Perkovic V;
    Diabetologia; 2019 Nov; 62(11):1988-1997. PubMed ID: 31302707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cause-specific mortality according to urine albumin creatinine ratio in the general population.
    Skaaby T; Husemoen LL; Ahluwalia TS; Rossing P; Jørgensen T; Thuesen BH; Pisinger C; Rasmussen K; Linneberg A
    PLoS One; 2014; 9(3):e93212. PubMed ID: 24675825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers.
    Heerspink HJL; Sjöström CD; Inzucchi SE; Hallow MK; Cain VA; Rossing P; Stefansson BV; Sartipy P
    Diabetes Obes Metab; 2019 Mar; 21(3):720-725. PubMed ID: 30414240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial.
    Muskiet MHA; Tonneijck L; Huang Y; Liu M; Saremi A; Heerspink HJL; van Raalte DH
    Lancet Diabetes Endocrinol; 2018 Nov; 6(11):859-869. PubMed ID: 30292589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between 1-year changes in urinary albumin-to-creatinine ratio and kidney disease progression in Japanese individuals with diabetes: a historical cohort study.
    Babazono T; Hanai K; Yokoyama Y; Uchiyama K
    Clin Exp Nephrol; 2023 Dec; 27(12):1001-1009. PubMed ID: 37606804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.
    Ninomiya T; Perkovic V; de Galan BE; Zoungas S; Pillai A; Jardine M; Patel A; Cass A; Neal B; Poulter N; Mogensen CE; Cooper M; Marre M; Williams B; Hamet P; Mancia G; Woodward M; Macmahon S; Chalmers J;
    J Am Soc Nephrol; 2009 Aug; 20(8):1813-21. PubMed ID: 19443635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial.
    Persson F; Bain SC; Mosenzon O; Heerspink HJL; Mann JFE; Pratley R; Raz I; Idorn T; Rasmussen S; von Scholten BJ; Rossing P;
    Diabetes Care; 2021 Apr; 44(4):1020-1026. PubMed ID: 33504496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between urinary albumin to creatinine ratio and all-cause mortality in the elderly population in the Chinese community: a 10-year follow-up study.
    Zhang A; Li M; Qiu J; Sun J; Su Y; Cai S; Bao Q; Cheng B; Ma S; Zhang Y; Wang S; Zhu P
    BMC Nephrol; 2022 Jan; 23(1):16. PubMed ID: 34983421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study.
    Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE; Dahlöf B; Snapinn SM; Wan Y; Lyle PA
    Diabetes Care; 2006 Mar; 29(3):595-600. PubMed ID: 16505512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.
    Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Erondu N; Shaw W; Barrett TD; Weidner-Wells M; Deng H; Matthews DR; Neal B
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):691-704. PubMed ID: 29937267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.